Incorporating Economic Evidence in Clinical Guidelines: A Framework From the Clinical Guidelines Committee of the American College of Physicians

被引：0

作者：

Qaseem, Amir ^{[1
]}

Shamliyan, Tatyana ^{[1
]}

Owens, Douglas K. ^{[2
]}

Tice, Jeffrey A. ^{[3
]}

Crandall, Carolyn J. ^{[4
]}

Clinical Guidelines Committee of the American College of Physicians, Lauri A.

机构：

[1] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA

[2] Stanford Univ, Stanford, CA USA

[3] Univ Calif San Francisco, San Francisco, CA USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

来源：

ANNALS OF INTERNAL MEDICINE | 2025年 / 178卷 / 02期

关键词：

COST-EFFECTIVENESS THRESHOLDS; GRADE APPROACH; HEALTH; RECOMMENDATIONS; AUTHORS;

D O I：

10.7326/ANNALS-24-02149

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In recognition of accelerating health care spending and alignment with the American College of Physicians (ACP) principles of promoting high-value care, the ACP Clinical Guidelines Committee (CGC) developed a framework to standardize its approach to identifying, appraising, and considering economic evidence in the development of ACP clinical guidelines. This article presents the CGC's process for incorporating economic evidence, which encompasses cost-effectiveness analyses, economic outcomes in randomized controlled trials, and resource utilization (intervention cost) data. Economic evidence is one component of ACP recommendations. The CGC first and foremost assesses the certainty of evidence for clinical net benefit of interventions; it then considers patient values and preferences, and only then considers economic evidence to develop recommendations.

引用

页码：241 / 248

页数：14

共 44 条

[1] Owens DK, Qaseem A, Chou R, Et al., High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions, Ann Intern Med, 154, pp. 174-180, (2011)
[2] Gunja MZ, Gumas ED, Williams RD, U.S. Health Care from a Global Perspective, 2022: Accelerating Spending, Worsening Outcomes
[3] Current health expenditure per capita (current US$)
[4] National Health Expenditure Accounts and Health, United States, (2022)
[5] Keehan SP, Fiore JA, Poisal JA, Et al., National health expenditure projections, 2022–31: growth to stabilize once the COVID-19 public health emergency ends, Health Aff (Millwood), 42, pp. 886-898, (2023)
[6] Shrank WH, Rogstad TL, Parekh N., Waste in the US health care system: estimated costs and potential for savings, JAMA, 322, pp. 1501-1509, (2019)
[7] Segal JB, Sen AP, Glanzberg-Krainin E, Et al., Factors associated with overuse of health care within US health systems: a cross-sectional analysis of Medicare beneficiaries from 2016 to 2018, JAMA Health Forum, 3, (2022)
[8] Schwartz AL, Jena AB, Zaslavsky AM, Et al., Analysis of physician variation in provision of low-value services, JAMA Intern Med, 179, pp. 16-25, (2019)
[9] Qaseem A, Kansagara D, Lin JS, Et al., The development of clinical guidelines and guidance statements by the Clinical Guidelines Committee of the American College of Physicians: update of methods, Ann Intern Med, 170, pp. 863-870, (2019)
[10] Cost-Effectiveness Analysis

← 1 2 3 4 5 →